Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended coverage for Medicaid recipients.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.

“I love Thanksgiving for the pumpkin pie — it's such a low-sugar dessert that it tends to be fine for your blood sugar,” Bensley tells PEOPLE. “Chocolate is okay, but just try to do it with your meal to keep that blood sugar stable.”

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

The Biden administration on Tuesday proposed requiring Medicare and Medicaid to cover anti-obesity drugs. Why it matters: The rule would expand access to the medications for millions of Americans struggling with obesity,

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.